The state of Nebraska currently has 3 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including Omaha, Lincoln, Kearney and Grand Island.
Altropane Dose for Imaging Patients With Suspected Parkinson's Disease
Recruiting
Previous studies showed that a dose of 8 millicuries of Altropane was appropriate for imaging patients with suspected Parkinson's disease. This study will determine if a lower dose (5 millicuries) would suffice.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/02/2024
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Parkinson Disease, Movement Disorders
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
Recruiting
This is an open-label, non-randomized, proof-of-concept comparison of clinical vs. research stimulation patterns in patients with Parkinson's disease (PD) being treated with Deep Brain Stimulation (DBS) through the Medtronic Percept PC DBS device. The investigators hypothesize that stimulation patterns designed to better target excessive synchrony in a patient-tailored manner may result in more efficient and effective therapy with fewer side effects. Medtronic 3rd-generation sensing implantable... Read More
Gender:
All
Ages:
Between 19 years and 80 years
Trial Updated:
01/10/2024
Locations: Unversity of Nebraska Medical Center, Omaha, Nebraska
Conditions: Parkinson's Disease
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
Recruiting
This study is aimed at testing the hypothesis that adaptive stimulation of the Subthalamic Nucleus (STN) drives changes in sleep episode maintenance and improves sleep quality. Investigators will directly test the efficacy of an adaptive stimulation protocol. Study subjects are adults with Parkinson's disease who experience inadequate motor symptom relief, and who have been offered implantation of a deep brain stimulator system targeting STN for the treatment of motor symptoms (standard-of-care)... Read More
Gender:
All
Ages:
Between 19 years and 80 years
Trial Updated:
10/19/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Parkinson's Disease, Sleep Fragmentation